Read more

December 03, 2020
1 min watch
Save

VIDEO: Efficacy comparisons in ‘advent’ of new anti-VEGF agents

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video, Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine, highlighted Diana Do’s comparisons in anti-VEGF efficacy at the virtual American Academy of Ophthalmology annual meeting.

“With the advent of the newer anti-VEGF agents that have come out this year and last few years, I'm interested to see how what data she presents on how they stack up against each other,” Singh said. “From a clinical side, I feel that there are some differences in some of these drugs, albeit some of the clinical trials haven't shown those significant differences yet. It will be interesting to watch her presentation and see if she's able to heighten our awareness of new studies.”